Klacid

Clarithromycin, the active ingredient in Klacid, is a macrolide presented as an oral tablet for oral use. It treats a range of bacterial infections, including respiratory and skin infections, and is used in combination regimens for Helicobacter pylori eradication. GNH USA supplies Klacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is a macrolide antibiotic that targets a variety of bacterial infections across several organ systems. Community‑acquired pneumonia: resolves infection and improves pulmonary function. Acute bacterial sinusitis: reduces sinus inflammation and bacterial load. Acute exacerbations of chronic bronchitis: shortens symptom duration and prevents complications. Skin and soft‑tissue infections: eradicates susceptible Gram‑positive and some Gram‑negative pathogens. Helicobacter pylori eradication (in combination therapy): contributes to bacterial clearance when used with a proton‑pump inhibitor and another antimicrobial.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Abdominal pain: cramping or discomfort. - Taste disturbance: altered taste perception. - Headache: mild to moderate intensity. - Vomiting: occasional episodes.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - QT interval prolongation: potential cardiac arrhythmias. - Clostridioides difficile infection: severe colitis. - Hepatotoxicity: elevated liver enzymes or jaundice. - Cardiac arrhythmias: especially in patients with pre‑existing heart disease. - Stevens‑Johnson syndrome: rare but serious skin reaction.

Before prescribing Clarithromycin, clinicians should consider several safety factors. - Assess renal function: adjust dosing in impaired kidneys. - Monitor liver enzymes: watch for signs of hepatotoxicity. - Avoid use in patients with known macrolide allergy: risk of hypersensitivity. - Use caution in patients with cardiac arrhythmias: potential QT prolongation. - Store at room temperature: keep in the original container, protect from moisture.

Clarithromycin interacts with several medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Cisapride: risk of serious cardiac events. - Erythromycin: additive QT prolongation. - Theophylline: increased serum concentrations. - Warfarin: enhanced anticoagulant effect. - Digoxin: elevated plasma levels.

Moderate Interactions (Monitor Closely): - Statins (e.g., simvastatin): increased risk of myopathy. - Carbamazepine: reduced clarithromycin exposure. - Oral contraceptives: possible decreased efficacy.